BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmedo H, Marx C, Ebert A, Kreft B, Ko Y, Türler A, Vorreuther R, Göhring U, Schild HH, Gerhardt T, Pöge U, Ezziddin S, Biersack H, Ahmadzadehfar H. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging 2014;41:59-67. [DOI: 10.1007/s00259-013-2532-6] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Ichikawa H, Shibutani T, Onoguchi M, Taniguchi Y. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT. Ann Nucl Med 2022. [PMID: 36048347 DOI: 10.1007/s12149-022-01783-z] [Reference Citation Analysis]
2 Nalliah S, Zacho HD. The value of 68Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging. Nucl Med Commun 2022. [PMID: 35950348 DOI: 10.1097/MNM.0000000000001602] [Reference Citation Analysis]
3 Shiiba T, Sekikawa Y, Tateoka S, Shinohara N, Inoue Y, Kuroiwa Y, Tanaka T, Kihara Y, Imamura T. Verification of the effect of acquisition time for SwiftScan on quantitative bone single-photon emission computed tomography using an anthropomorphic phantom. EJNMMI Phys 2022;9:48. [PMID: 35907090 DOI: 10.1186/s40658-022-00477-9] [Reference Citation Analysis]
4 Usmani S, Ahmed N, Gnanasegaran G, Al Kandari F, Marafi F, Bani-Mustafa A, Musbah A, Jassem Almashmoum M, Van den Wyngaert T. Prospective study of Na[18F]F PET/CT for cancer staging in morbidly obese patients compared with [99mTc]Tc-MDP whole-body planar, SPECT and SPECT/CT. Acta Oncol 2022;:1-10. [PMID: 35862646 DOI: 10.1080/0284186X.2022.2101899] [Reference Citation Analysis]
5 Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study. BMJ Open 2022;12:e058898. [PMID: 35705343 DOI: 10.1136/bmjopen-2021-058898] [Reference Citation Analysis]
6 Fukai S, Daisaki H, Umeda T, Shimada N, Miyaji N, Ito R, Takiguchi T, Terauchi T. Impact of patient body habitus on image quality and quantitative value in bone SPECT/CT. Ann Nucl Med 2022. [PMID: 35543916 DOI: 10.1007/s12149-022-01746-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bhaludin BN, Tunariu N, Koh DM, Messiou C, Okines AF, McGrath SE, Ring AE, Parton MM, Sharma B, Gagliardi T, Allen SD, Pope R, Johnston SRD, Downey K. A review on the added value of whole-body MRI in metastatic lobular breast cancer. Eur Radiol 2022. [PMID: 35384456 DOI: 10.1007/s00330-022-08714-6] [Reference Citation Analysis]
8 Zacho HD, Ravn S, Ejlersen JA, Fledelius J, Dolliner P, Nygaard ST, Holdgaard PC, Lauridsen JF, Haarmark C, Hendel HW, Petersen LJ. Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. Nucl Med Commun 2022:MNM. [PMID: 35362691 DOI: 10.1097/MNM.0000000000001550] [Reference Citation Analysis]
9 Tan MT, Lloyd TB. Utility of dual energy computed tomography in the evaluation of infiltrative skeletal lesions and metastasis: a literature review. Skeletal Radiol 2022. [PMID: 35294599 DOI: 10.1007/s00256-022-04032-6] [Reference Citation Analysis]
10 Bebbington NA, Zacho HD, Holdgaard PC. Lesion detection in 18F-sodium fluoride bone imaging: a comparison of attenuation-corrected versus nonattenuation-corrected PET reconstructions from modern PET-CT systems. Nucl Med Commun 2022;43:78-85. [PMID: 34887371 DOI: 10.1097/MNM.0000000000001487] [Reference Citation Analysis]
11 Yamane T, Takahashi M, Matsusaka Y, Fukushima K, Seto A, Kuji I, Matsunari I. Satisfied quantitative value can be acquired by short-time bone SPECT/CT using a whole-body cadmium-zinc-telluride gamma camera. Sci Rep 2021;11:24320. [PMID: 34934145 DOI: 10.1038/s41598-021-03853-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ichikawa H, Miyaji N, Onoguchi M, Shibutani T, Nagaki A, Kato T, Shimada H. Feasibility of ultra-high-speed acquisition in xSPECT bone algorithm: a phantom study with advanced bone SPECT-specific phantom. Ann Nucl Med 2021. [PMID: 34731435 DOI: 10.1007/s12149-021-01689-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Mohd Rohani MF, Zanial AZ, Suppiah S, Phay Phay K, Mohamed Aslum Khan F, Mohamad Najib FH, Mohd Noor N, Arumugam M, Amir Hassan SZ, Vinjamuri S. Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further work. Nucl Med Commun 2021;42:9-20. [PMID: 33165258 DOI: 10.1097/MNM.0000000000001306] [Reference Citation Analysis]
14 Ito T, Tsuchikame H, Ichikawa H, Onoguchi M, Okuda K, Shibutani T, Yokotsuka N, Tomizawa H. Verification of phantom accuracy using a Monte Carlo simulation: bone scintigraphy chest phantom. Radiol Phys Technol 2021;14:336-44. [PMID: 34302616 DOI: 10.1007/s12194-021-00631-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Ishihara M, Kato Y, Onoguchi M, Shibutani T. An alternative method for radioactivity measurement in quantitative bone SPECT/CT imaging. Sci Prog 2021;104:368504211028363. [PMID: 34231449 DOI: 10.1177/00368504211028363] [Reference Citation Analysis]
16 Zhang J, Zhai G, Yang B, Liu Z. Computerized Tomography (CT) Updates and Challenges in Diagnosis of Bone Metastases During Prostate Cancer. Curr Med Imaging 2020;16:565-71. [PMID: 32484090 DOI: 10.2174/1573405614666181009144601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Binte Alam S, Nii M, Shimizu A, Kobashi S. Spatiotemporal Statistical Shape Model for Temporal Shape Change Analysis of Adult Brain. Curr Med Imaging 2020;16:499-506. [PMID: 32484084 DOI: 10.2174/1573405615666181120141147] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Van Nieuwenhove S, Van Damme J, Padhani AR, Vandecaveye V, Tombal B, Wuts J, Pasoglou V, Lecouvet FE. Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions. J Magn Reson Imaging 2020. [PMID: 33382151 DOI: 10.1002/jmri.27485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Mostafa R, Abdelhafez YG, Abougabal M, Nardo L, Elkareem MA. Two-bed SPECT/CT versus planar bone scintigraphy: prospective comparison of reproducibility and diagnostic performance. Nucl Med Commun 2021;42:360-8. [PMID: 33346602 DOI: 10.1097/MNM.0000000000001353] [Reference Citation Analysis]
20 Alqahtani M, Fulton R, Constable C, Willowson K, Kench P. Diagnostic performance of whole-body SPECT/CT in bone metastasis detection using 99mTc-labelled diphosphate: a systematic review and meta-analysis. Clinical Radiology 2020;75:961.e11-24. [DOI: 10.1016/j.crad.2020.07.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Lee JW, Park YJ, Jeon YS, Kim KH, Lee JE, Hong SH, Lee SM, Jang SJ. Clinical value of dual-phase F-18 sodium fluoride PET/CT for diagnosing bone metastasis in cancer patients with solitary bone lesion. Quant Imaging Med Surg 2020;10:2098-111. [PMID: 33139990 DOI: 10.21037/qims-20-607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Engur CO, Turoglu HT, Ozguven S, Tanidir Y, Erdil TY. 68Ga-Prostate-Specific Membrane Antigen PET-Positive Paget Bone Disease With Metastatic Prostatic Carcinoma. Clin Nucl Med 2020;45:e425-6. [PMID: 32701800 DOI: 10.1097/RLU.0000000000003198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 de Leiris N, Leenhardt J, Boussat B, Montemagno C, Seiller A, Phan Sy O, Roux J, Laramas M, Verry C, Iriart C, Fiard G, Long JA, Descotes JL, Vuillez JP, Riou L, Djaileb L. Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence? Cancer Imaging 2020;20:58. [PMID: 32787923 DOI: 10.1186/s40644-020-00333-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zacho HD, Aleksyniene R, Ejlersen JA, Fledelius J, Petersen LJ. Inter- and intraobserver agreement in standard and ultra-fast single-photon emission computed tomography/computed tomography for the assessment of bone metastases. Nucl Med Commun 2020;41:1005-9. [PMID: 32694282 DOI: 10.1097/MNM.0000000000001252] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Pesapane F, Downey K, Rotili A, Cassano E, Koh DM. Imaging diagnosis of metastatic breast cancer. Insights Imaging 2020;11:79. [PMID: 32548731 DOI: 10.1186/s13244-020-00885-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
26 Simsek DH, Sanli Y, Civan C, Engin MN, Isik EG, Ozkan ZG, Kuyumcu S. Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer? Ann Nucl Med 2020;34:476-85. [PMID: 32394269 DOI: 10.1007/s12149-020-01474-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 de Laroche R, Bourhis D, Robin P, Delcroix O, Querellou S, Malhaire JP, Schlurmann F, Bourbonne V, Salaün PY, Schick U, Abgral R. Feasibility Study and Preliminary Results of Prognostic Value of Bone SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma to Abiraterone. Front Med (Lausanne) 2019;6:342. [PMID: 32039220 DOI: 10.3389/fmed.2019.00342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
28 Jabeen N, Rasheed R, Rafique A, Murtaza G. The Established Nuclear Medicine Modalities for Imaging of Bone Metastases. CMIR 2019;15:819-30. [DOI: 10.2174/1573405614666180327122548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Zacho HD, Fonager RF, Nielsen JB, Haarmark C, Hendel HW, Johansen MB, Mortensen JC, Petersen LJ. Observer Agreement and Accuracy of 18F-Sodium Fluoride PET/CT in the Diagnosis of Bone Metastases in Prostate Cancer. J Nucl Med 2020;61:344-9. [PMID: 31481577 DOI: 10.2967/jnumed.119.232686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
30 Vaz S, Usmani S, Gnanasegaran G, Van den Wyngaert T. Molecular imaging of bone metastases using bone targeted tracers. Q J Nucl Med Mol Imaging 2019;63:112-28. [PMID: 31286752 DOI: 10.23736/S1824-4785.19.03198-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Israel O, Pellet O, Biassoni L, De Palma D, Estrada-Lobato E, Gnanasegaran G, Kuwert T, la Fougère C, Mariani G, Massalha S, Paez D, Giammarile F. Two decades of SPECT/CT - the coming of age of a technology: An updated review of literature evidence. Eur J Nucl Med Mol Imaging 2019;46:1990-2012. [PMID: 31273437 DOI: 10.1007/s00259-019-04404-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
32 Zhang L, He Q, Zhou T, Zhang B, Li W, Peng H, Zhong X, Ma L, Zhang R. Accurate characterization of 99mTc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT/CT. BMC Med Imaging 2019;19:44. [PMID: 31146746 DOI: 10.1186/s12880-019-0345-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Ross JC, Vilić D, Sanderson T, Vöö S, Dickson J. Does quantification have a role to play in the future of bone SPECT? Eur J Hybrid Imaging 2019;3:8. [PMID: 34191209 DOI: 10.1186/s41824-019-0054-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
34 Onoue K, Nishio M, Yakami M, Aoyama G, Nakagomi K, Iizuka Y, Kubo T, Emoto Y, Akasaka T, Satoh K, Yamamoto H, Isoda H, Togashi K. CT temporal subtraction improves early detection of bone metastases compared to SPECT. Eur Radiol 2019;29:5673-81. [PMID: 30888486 DOI: 10.1007/s00330-019-06107-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B. Novel Imaging in Detection of Metastatic Prostate Cancer. Curr Oncol Rep 2019;21. [DOI: 10.1007/s11912-019-0780-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
36 Kutaiba N, Ardalan Z, Patwala K, Lau E, Goodwin M, Gow P. Value of Bone Scans in Work-up of Patients With Hepatocellular Carcinoma for Liver Transplant. Transplant Direct 2018;4:e408. [PMID: 30584589 DOI: 10.1097/TXD.0000000000000846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Dyrberg E, Hendel HW, Løgager VB, Madsen C, Pedersen EM, Zerahn B, Thomsen HS. A prospective study determining and comparing the diagnostic accuracy of fluoride-PET/CT, choline-PET/CT, whole-body bone SPECT/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer. European J Hybrid Imaging 2018;2. [DOI: 10.1186/s41824-018-0038-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Xing Y, Zhu J, Zhao L, Xiong Z, Li Y, Wu S, Chand G, Shi X, Zhao J. SPECT/CT imaging of chemotherapy-induced tumor apoptosis using 99mTc-labeled dendrimer-entrapped gold nanoparticles. Drug Deliv 2018;25:1384-93. [PMID: 29869521 DOI: 10.1080/10717544.2018.1474968] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
39 Lecouvet FE, Oprea-lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot J, Zacho H, Tombal B, deSouza NM. Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group. The Lancet Oncology 2018;19:e534-45. [DOI: 10.1016/s1470-2045(18)30571-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 67] [Article Influence: 12.8] [Reference Citation Analysis]
40 Pesapane F, Czarniecki M, Suter MB, Turkbey B, Villeirs G. Imaging of distant metastases of prostate cancer. Med Oncol 2018;35. [DOI: 10.1007/s12032-018-1208-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
41 Malaspina S, De Giorgi U, Kemppainen J, Del Sole A, Paganelli G. 68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer. Radiol Med 2018;123:952-65. [PMID: 30116970 DOI: 10.1007/s11547-018-0929-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
42 Fleury V, Ferrer L, Colombié M, Rusu D, Le Thiec M, Kraeber-Bodéré F, Campion L, Rousseau C. Advantages of systematic trunk SPECT/CT to planar bone scan (PBS) in more than 300 patients with breast or prostate cancer. Oncotarget 2018;9:31744-52. [PMID: 30167091 DOI: 10.18632/oncotarget.25860] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
43 Bjurlin MA, Turkbey B, Rosenkrantz AB, Gaur S, Choyke PL, Taneja SS. Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging. Urology 2018;116:3-12. [DOI: 10.1016/j.urology.2017.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
44 Gregoire B, Pina-jomir G, Bani-sadr A, Moreau-triby C, Janier M, Scheiber C. Four-Minute Bone SPECT Using Large-Field Cadmium-Zinc-Telluride Camera. Clin Nucl Med 2018;43:389-95. [DOI: 10.1097/rlu.0000000000002062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
45 Xiao Z, Song Y, Kai W, Sun X, Shen B. Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC. Oncotarget 2017;8:40732-40. [PMID: 28489575 DOI: 10.18632/oncotarget.17251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Petersen LJ, Strandberg J, Stenholt L, Johansen MB, Zacho HD. Reporting and Handling of Indeterminate Bone Scan Results in the Staging of Prostate Cancer: A Systematic Review. Diagnostics (Basel) 2018;8:E9. [PMID: 29337860 DOI: 10.3390/diagnostics8010009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
47 Zacho HD, Nielsen JB, Haberkorn U, Stenholt L, Petersen LJ. 68 Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature. Clin Physiol Funct Imaging 2018;38:911-22. [DOI: 10.1111/cpf.12480] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
48 Kuji I, Yamane T, Seto A, Yasumizu Y, Shirotake S, Oyama M. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. Eur J Hybrid Imaging 2017;1:2. [PMID: 29782587 DOI: 10.1186/s41824-017-0006-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
49 Wu ZQ, Chen XT, Xu YY, Tian MJ, Chen HY, Zhou GP, Xu HG. High uric acid (UA) downregulates bone alkaline phosphatase (BALP) expression through inhibition of its promoter activity. Oncotarget 2017;8:85670-9. [PMID: 29156749 DOI: 10.18632/oncotarget.21110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Usmani S, Marafi F, Ahmed N, Esmail A, Al Kandari F, Van den Wyngaert T. Diagnostic Challenge of Staging Metastatic Bone Disease in the Morbidly Obese Patients: A Primary Study Evaluating the Usefulness of 18F-Sodium Fluoride (NaF) PET-CT. Clin Nucl Med 2017;42:829-36. [PMID: 28872551 DOI: 10.1097/RLU.0000000000001823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
51 Löfgren J, Mortensen J, Rasmussen SH, Madsen C, Loft A, Hansen AE, Oturai P, Jensen KE, Mørk ML, Reichkendler M, Højgaard L, Fischer BM. A Prospective Study Comparing 99mTc-Hydroxyethylene-Diphosphonate Planar Bone Scintigraphy and Whole-Body SPECT/CT with 18F-Fluoride PET/CT and 18F-Fluoride PET/MRI for Diagnosing Bone Metastases. J Nucl Med 2017;58:1778-85. [PMID: 28798033 DOI: 10.2967/jnumed.116.189183] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
52 Rager O, Nkoulou R, Exquis N, Garibotto V, Tabouret-Viaud C, Zaidi H, Amzalag G, Lee-Felker SA, Zilli T, Ratib O. Whole-Body SPECT/CT versus Planar Bone Scan with Targeted SPECT/CT for Metastatic Workup. Biomed Res Int 2017;2017:7039406. [PMID: 28812019 DOI: 10.1155/2017/7039406] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
53 Zhang L, He Q, Li W, Zhang R. The value of 99mTc-methylene diphosphonate single photon emission computed tomography/computed tomography in diagnosis of fibrous dysplasia. BMC Med Imaging 2017;17:46. [PMID: 28738834 DOI: 10.1186/s12880-017-0218-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Nakahara T, Daisaki H, Yamamoto Y, Iimori T, Miyagawa K, Okamoto T, Owaki Y, Yada N, Sawada K, Tokorodani R, Jinzaki M. Use of a digital phantom developed by QIBA for harmonizing SUVs obtained from the state-of-the-art SPECT/CT systems: a multicenter study. EJNMMI Res 2017;7:53. [PMID: 28639254 DOI: 10.1186/s13550-017-0300-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
55 Guezennec C, Keromnes N, Robin P, Abgral R, Bourhis D, Querellou S, de Laroche R, Le Duc-Pennec A, Salaün PY, Le Roux PY. Incremental diagnostic utility of systematic double-bed SPECT/CT for bone scintigraphy in initial staging of cancer patients. Cancer Imaging 2017;17:16. [PMID: 28592305 DOI: 10.1186/s40644-017-0118-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
56 Ogata Y, Nakahara T, Ode K, Matsusaka Y, Katagiri M, Iwabuchi Y, Itoh K, Ichimura A, Jinzaki M. 3D SPECT/CT fusion using image data projection of bone SPECT onto 3D volume-rendered CT images: feasibility and clinical impact in the diagnosis of bone metastasis. Ann Nucl Med 2017;31:304-14. [PMID: 28243844 DOI: 10.1007/s12149-017-1158-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
57 Zacho HD, Manresa JAB, Aleksyniene R, Ejlersen JA, Fledelius J, Bertelsen H, Petersen LJ. Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT. EJNMMI Res 2017;7:1. [PMID: 28058659 DOI: 10.1186/s13550-016-0252-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
58 Reinfelder J, Kuwert T, Beck M, Sanders JC, Ritt P, Schmidkonz C, Hennig P, Prante O, Uder M, Wullich B, Goebell P. First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer. Clinical Nuclear Medicine 2017;42:26-33. [DOI: 10.1097/rlu.0000000000001433] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
59 Mahaletchumy T, AbAziz A. Incremental Value of Single-photon Emission Computed Tomography-computed Tomography for Characterization of Skeletal Lesions in Breast Cancer Patients. World J Nucl Med 2017;16:303-10. [PMID: 29033679 DOI: 10.4103/1450-1147.215496] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
60 Simanek M, Koranda P. SPECT/CT imaging in breast cancer - current status and challenges. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2016;160:474-83. [DOI: 10.5507/bp.2016.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
61 Grávalos C, Rodríguez C, Sabino A, Seguí MÁ, Virizuela JA, Carmona A, Cassinello J, Isla D, Jara C, Martín M. SEOM Clinical Guideline for bone metastases from solid tumours (2016). Clin Transl Oncol 2016;18:1243-53. [PMID: 27896639 DOI: 10.1007/s12094-016-1590-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
62 Langsteger W, Rezaee A, Pirich C, Beheshti M. 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer. Seminars in Nuclear Medicine 2016;46:491-501. [DOI: 10.1053/j.semnuclmed.2016.07.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 8.5] [Reference Citation Analysis]
63 Abikhzer G, Gourevich K, Kagna O, Israel O, Frenkel A, Keidar Z. Whole-body bone SPECT in breast cancer patients: the future bone scan protocol? Nucl Med Commun 2016;37:247-53. [PMID: 26528786 DOI: 10.1097/MNM.0000000000000427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
64 Tootell A, McEntee M, Szczepura K, Hogg P. Effective Dose and Effective Risk from Post-Single Photon Emission Computed Tomography Imaging of the Lumbar Spine. J Med Imaging Radiat Sci 2016;47:267-75. [PMID: 31047291 DOI: 10.1016/j.jmir.2016.04.012] [Reference Citation Analysis]
65 Van den Wyngaert T, Strobel K, Kampen WU, Kuwert T, van der Bruggen W, Mohan HK, Gnanasegaran G, Delgado-Bolton R, Weber WA, Beheshti M, Langsteger W, Giammarile F, Mottaghy FM, Paycha F; EANM Bone & Joint Committee and the Oncology Committee. The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging 2016;43:1723-38. [PMID: 27262701 DOI: 10.1007/s00259-016-3415-4] [Cited by in Crossref: 146] [Cited by in F6Publishing: 138] [Article Influence: 24.3] [Reference Citation Analysis]
66 Cook GJ, Azad GK, Goh V. Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment. J Nucl Med 2016;57 Suppl 1:27S-33S. [PMID: 26834098 DOI: 10.2967/jnumed.115.157867] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
67 Waller ML, Chowdhury FU. The basic science of nuclear medicine. Orthopaedics and Trauma 2016;30:201-22. [DOI: 10.1016/j.mporth.2016.05.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
68 Amzalag G, Rager O, Tabouret-Viaud C, Wissmeyer M, Sfakianaki E, de Perrot T, Ratib O, Miralbell R, Giovacchini G, Garibotto V, Zilli T. Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging. Front Oncol 2016;6:73. [PMID: 27065024 DOI: 10.3389/fonc.2016.00073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
69 Sibille L, Chambert B, Alonso S, Barrau C, D’estanque E, Al Tabaa Y, Collombier L, Demattei C, Kotzki P, Boudousq V. Impact of the Adaptive Statistical Iterative Reconstruction Technique on Radiation Dose and Image Quality in Bone SPECT/CT. J Nucl Med 2016;57:1091-5. [DOI: 10.2967/jnumed.115.164772] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
70 Mahajan A, Azad GK, Cook GJ. PET Imaging of Skeletal Metastases and Its Role in Personalizing Further Management. PET Clin. 2016;11:305-318. [PMID: 27321034 DOI: 10.1016/j.cpet.2016.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
71 Jha AK, Caffo B, Frey EC. A no-gold-standard technique for objective assessment of quantitative nuclear-medicine imaging methods. Phys Med Biol 2016;61:2780-800. [PMID: 26982626 DOI: 10.1088/0031-9155/61/7/2780] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
72 Evangelista L, Bertoldo F, Boccardo F, Conti G, Menchi I, Mungai F, Ricardi U, Bombardieri E. Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons. Eur J Nucl Med Mol Imaging 2016;43:1546-62. [PMID: 26956538 DOI: 10.1007/s00259-016-3350-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
73 Petersen LJ, Mortensen JC, Bertelsen H, Zacho HD. Computer-assisted interpretation of planar whole-body bone scintigraphy in patients with newly diagnosed prostate cancer. Nucl Med Commun 2015;36:679-85. [PMID: 25757196 DOI: 10.1097/MNM.0000000000000307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fonager RF, Zacho HD, Langkilde NC, Petersen LJ. (18)F-fluoride positron emission tomography/computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: study protocol for a multicentre, diagnostic test accuracy study. BMC Cancer 2016;16:10. [PMID: 26753880 DOI: 10.1186/s12885-016-2047-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
75 Azad GK, Taylor B, Rubello D, Colletti PM, Goh V, Cook GJ. Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. Clinical Nuclear Medicine 2016;41:e44-50. [DOI: 10.1097/rlu.0000000000000993] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
76 Lange MB, Nielsen ML, Andersen JD, Lilholt HJ, Vyberg M, Petersen LJ. Diagnostic accuracy of imaging methods for the diagnosis of skeletal malignancies: A retrospective analysis against a pathology-proven reference. European Journal of Radiology 2016;85:61-7. [DOI: 10.1016/j.ejrad.2015.10.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
77 Zacho HD, Manresa JA, Mortensen JC, Bertelsen H, Petersen LJ. Observer agreement and accuracy in the evaluation of bone scans in newly diagnosed prostate cancer. Nucl Med Commun 2015;36:445-51. [PMID: 25646705 DOI: 10.1097/MNM.0000000000000279] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
78 Rowe SP, Mana-Ay M, Javadi MS, Szabo Z, Leal JP, Pomper MG, Pienta KJ, Ross AE, Gorin MA. PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT? Clin Genitourin Cancer 2016;14:e115-8. [PMID: 26603549 DOI: 10.1016/j.clgc.2015.09.011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
79 Wale DJ, Wong KK, Savas H, Kandathil A, Piert M, Brown RK. Extraosseous Findings on Bone Scintigraphy Using Fusion SPECT/CT and Correlative Imaging. AJR Am J Roentgenol 2015;205:160-72. [PMID: 26102395 DOI: 10.2214/AJR.14.13914] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
80 Beheshti M, Mottaghy FM, Paycha F, Behrendt FFF, Van den Wyngaert T, Fogelman I, Strobel K, Celli M, Fanti S, Giammarile F, Krause B, Langsteger W. (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging 2015;42:1767-77. [PMID: 26201825 DOI: 10.1007/s00259-015-3138-y] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]
81 Trout AT, Sharp SE, Anton CG, Gelfand MJ, Mehlman CT. Spondylolysis and Beyond: Value of SPECT/CT in Evaluation of Low Back Pain in Children and Young Adults. RadioGraphics 2015;35:819-34. [DOI: 10.1148/rg.2015140092] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
82 Greene LR, Wilkinson D. The role of general nuclear medicine in breast cancer. J Med Radiat Sci 2015;62:54-65. [PMID: 26229668 DOI: 10.1002/jmrs.97] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
83 McLoughlin LC, O'Kelly F, O'Brien C, Sheikh M, Feeney J, Torreggiani W, Thornhill JA. The improved accuracy of planar bone scintigraphy by adding single photon emission computed tomography (SPECT-CT) to detect skeletal metastases from prostate cancer. Ir J Med Sci 2016;185:101-5. [PMID: 25394725 DOI: 10.1007/s11845-014-1228-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
84 Larson SM. Better use of bone scans in prostate cancer. Nat Rev Urol 2015;12:190-1. [DOI: 10.1038/nrurol.2014.305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
85 Haraldsen A, Bluhme H, Røhl L, Pedersen EM, Jensen AB, Hansen EB, Nellemann H, Rasmussen F, Morsing A. Single photon emission computed tomography (SPECT) and SPECT/low-dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer. Clin Physiol Funct Imaging 2016;36:40-6. [DOI: 10.1111/cpf.12191] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
86 Jung K, Lein M. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta 2014;1846:425-38. [PMID: 25220832 DOI: 10.1016/j.bbcan.2014.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
87 Beckers C, Hustinx R. SPECT/CT workflow and imaging protocols. Eur J Nucl Med Mol Imaging 2014;41 Suppl 1:S137-45. [PMID: 24318158 DOI: 10.1007/s00259-013-2629-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
88 Okuda K, Fujii S, Sakimoto S. Impact of Novel Incorporation of CT-based Segment Mapping into a Conjugated Gradient Algorithm on Bone SPECT Imaging: Fundamental Characteristics of a Context-specific Reconstruction Method. Asia Ocean J Nucl Med Biol 2019;7:49-57. [PMID: 30705911 DOI: 10.22038/AOJNMB.2018.31711.1219] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Ichikawa H, Miwa K, Okuda K, Shibutani T, Kato T, Nagaki A, Tsushima H, Onoguchi M. Current state of bone scintigraphy protocols and practice in Japan. Asia Ocean J Nucl Med Biol 2020;8:116-22. [PMID: 32714999 DOI: 10.22038/AOJNMB.2020.44923.1302] [Cited by in F6Publishing: 2] [Reference Citation Analysis]